{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:01:28Z","timestamp":1780704088110,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.transci.2024.103912","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T03:11:29Z","timestamp":1710385889000},"page":"103912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlation between serum cytokine levels and the effect of allogeneic serum-based eye drops"],"prefix":"10.1016","volume":"63","author":[{"given":"Katarzyna","family":"Chmielewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Janus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Miko\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Wrzodak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"St\u0105cel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Antoniewicz-Papis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2024.103912_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5603\/OJ.2023.0011","article-title":"30-year experience of the institute of hematology and transfusion medicine, warsaw, Poland in dry eye syndrome treatment using autologous serum eye drops","volume":"8","author":"Janus","year":"2023","journal-title":"Ophthalmol J"},{"key":"10.1016\/j.transci.2024.103912_bib2","unstructured":"Szandruk M., Skrzypiec-Spring M., Szel\u0105g A. Leczenie i profilaktyka zespo\u0142u suchego oka. Strzelectwo sportowe. 2015;(12). \u3008https:\/\/www.pzss.org.pl\/assets\/files\/biblioteka-trenera\/2015\/04_2015_szandruk-skrzypiec-szelag-leczenie-i-profilaktyka-zespolu-suchego-oka.pdf\u3009. Accessed 2015."},{"issue":"5","key":"10.1016\/j.transci.2024.103912_bib3","first-page":"42","article-title":"Diagnostyka zespo\u0142u suchego oka w praktyce okulistycznej","author":"Ambroziak","year":"2010","journal-title":"Optyka"},{"key":"10.1016\/j.transci.2024.103912_bib4","first-page":"60","article-title":"Zesp\u00f3\u0142 \u201csuchego oka\u201d-mo\u017cliwo\u015bci leczenia z wykorzystaniem autologicznych \u201csztucznych \u0142ez\u201d","volume":"2","author":"Janik","year":"2016","journal-title":"J. Transf Med."},{"key":"10.1016\/j.transci.2024.103912_bib5","doi-asserted-by":"crossref","unstructured":"K\u0105kol P.T. Biologia. Kompendium. \u015awiat Ksi\u0105\u017cki. 2010Bernabei F, Roda M, Buzzi M, Pellegrini M, Giannaccare G, Versura P. Blood-based treatments for severe dry eye disease: The need of a consensus. J Clin Med. 2019;8(9). doi: 10.3390\/jcm8091478.","DOI":"10.3390\/jcm8091478"},{"issue":"0","key":"10.1016\/j.transci.2024.103912_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5603\/OJ.2023.0011","article-title":"30-year experience of the institute of hematology and transfusion medicine, warsaw, Poland in dry eye syndrome treatment using autologous serum eye drops","volume":"8","author":"Janus","year":"2023","journal-title":"Ophthalmol J"},{"issue":"12","key":"10.1016\/j.transci.2024.103912_bib7","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1038\/s41433-021-01526-w","article-title":"Reducing the burden of ocular surface disease with serum eye drops","volume":"5","author":"Hossain","year":"2023","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.transci.2024.103912_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICU.0000000000000569","article-title":"Advances in dry eye disease treatment","volume":"30","author":"O\u2019Neil","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.transci.2024.103912_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/aos.14788","article-title":"Allogeneic and autologous serum eye drops: a pilot double-blind randomized crossover trial","volume":"99","author":"van der Meer","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.transci.2024.103912_bib10","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/ijms24021567","article-title":"Development of In vitro dry eye models to study proliferative and anti-inflammatory effects of allogeneic serum eye drops","volume":"24","author":"Vo\u00df","year":"2023","journal-title":"Int. J. Mol Sci."},{"issue":"5","key":"10.1016\/j.transci.2024.103912_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5114\/reum.2013.38388","article-title":"Przegla\u0105d metod diagnostycznych zespo\u0142u Sj\u00f6grena","volume":"51","author":"W\u0142odkowska-Korytkowska","year":"2013","journal-title":"Reumatologia"},{"issue":"9","key":"10.1016\/j.transci.2024.103912_bib12","article-title":"Low dose interleukin-2 ameliorates sj\u00f6gren\u2019s syndrome in a murine model","volume":"19","author":"Wang","year":"2022","journal-title":"Front Med."},{"issue":"9","key":"10.1016\/j.transci.2024.103912_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002901","article-title":"Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): a multicentre, open-label, randomised controlled trial","volume":"16","author":"Ruscitti","year":"2019","journal-title":"PLoS Med."},{"issue":"Suppl 3","key":"10.1016\/j.transci.2024.103912_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/ar582","article-title":"VEGF and imaging of vessels in rheumatoid arthritis","volume":"4","author":"Taylor","year":"2002","journal-title":"Arthritis Res."},{"issue":"14","key":"10.1016\/j.transci.2024.103912_bib15","doi-asserted-by":"crossref","first-page":"DES192","DOI":"10.1167\/iovs.17-23651","article-title":"Inflammatory response in dry eye","volume":"59","author":"Yamaguchi","year":"2018","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"10","key":"10.1016\/j.transci.2024.103912_bib16","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.4049\/jimmunol.1500117","article-title":"Cytokines in graft-versus-host disease","volume":"194","author":"Henden","year":"2015","journal-title":"J. Immunol"},{"issue":"1","key":"10.1016\/j.transci.2024.103912_bib17","first-page":"90","article-title":"Targeting cytokines in GVHD therapy","volume":"2","author":"Kumar","year":"2017","journal-title":"J. Immunol Res. Ther"},{"issue":"10","key":"10.1016\/j.transci.2024.103912_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152460","article-title":"Observation of influence of cataract surgery on the ocular surface","volume":"11","author":"Park","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.transci.2024.103912_bib19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/aos.12801","article-title":"Improving the anti-inflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction","volume":"93","author":"Stenwall","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.transci.2024.103912_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"10.1016\/j.transci.2024.103912_bib21","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1038\/s41433-021-01560-8","article-title":"Patient-reported outcome measures for a large cohort of serum eye drops recipients in the UK","volume":"35","author":"Lomas","year":"2021","journal-title":"Eye"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T12:26:49Z","timestamp":1716035209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1473050224000739"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.103912","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between serum cytokine levels and the effect of allogeneic serum-based eye drops","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.103912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103912"}}